The present invention concerns the use of tricyclic terpenes chosen from the group consisting of fusicoccin, ophiobolins or cotylenins for the therapy and diagnosis of coagulation-correlated pathologies such as Bernard-Soulier syndrome (BSS), von Willebrand disease (vWD), Glanzmann's thrombasthenia or thrombocytopenia
Camoni, L., Di Lucente, C., Visconti, S., Aducci, P. (2008). The fungal phytotoxin fusicoccin for the treatment and diagnosis of coagulation-correlated pathologies.
The fungal phytotoxin fusicoccin for the treatment and diagnosis of coagulation-correlated pathologies
CAMONI, LORENZO;VISCONTI, SABINA;ADUCCI, PATRIZIA
2008-05-23
Abstract
The present invention concerns the use of tricyclic terpenes chosen from the group consisting of fusicoccin, ophiobolins or cotylenins for the therapy and diagnosis of coagulation-correlated pathologies such as Bernard-Soulier syndrome (BSS), von Willebrand disease (vWD), Glanzmann's thrombasthenia or thrombocytopeniaFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
20110519_Letters Patent.pdf
accesso aperto
Descrizione: Brevetto
Licenza:
Non specificato
Dimensione
678.23 kB
Formato
Adobe PDF
|
678.23 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
